Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017. Issue 35 (14th August 2019)

• Record Type: Journal Article
• Authors: Ork, Vichit; Woodring, Joseph; Shafiqul Hossain, Md.; Wasley, Annemarie; Nagashima, Shintaro; Yamamoto, Chikako; Chuon, Channarena; Sugiyama, Aya; Ohisa, Masayuki; Akita, Tomoyuki; Ko, Ko; Mao, Bunsoth; Tanaka, Junko
• Is Part Of: Vaccine. Volume 37:Issue 35(2019)
• Page Start: 5059
• Page End: 5066
• Publication Date: 2019-08-14
• Subjects: Hepatitis B virus -- Cambodia -- Seroprevalence -- Vaccine; HBV Hepatitis B virus -- HBsAg hepatitis B surface antigen -- WHO World Health organization -- HepB-BD hepatitis B birth dose vaccine -- HepB hepatitis B vaccine; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2019.06.073
• Languages: English
• ISSNs: 0264-410X

Abstract

Highlights: This study proved of Cambodia achieving WHO 2017 target of <1% HBsAg prevalence. HBsAg prevalence in 5–7 years old children was 0.56% (95%CI: 0.32%–0.98%). HBsAg prevalence among the mothers was 4.39% (3.53%–5.45%). Among children with HBsAg-positive mother, prevalence was as high as 10.11%. 78.4% of children received HepB birth-dose and 58.7% were administered ≤24 h. Abstract: Background: Hepatitis B virus (HBV) infection is highly endemic in most low income countries including Cambodia. This nationwide serosurvey was conducted to assess the impact of hepatitis B vaccination and to determine whether Cambodia met the WHO regional 2017 target of hepatitis B surface antigen (HBsAg) seroprevalence less than 1% in five-year-old children. Methods: A cross-sectional multi-stage cluster survey was conducted among children born during 2010–2012 and their mothers in Cambodia. HBsAg prevalence was estimated by rapid point-of-care testing, and demographic data, including vaccination history, was collected. Vaccine coverage in children and the prevalence of HBsAg among children and mothers was calculated taking into account the complex survey design. Factors associated with children's failure to receive timely (within 24 h) vaccination were analysed by multivariate logistic analysis. Findings: A total of 2, 520 children 5–7 years old and 2, 028 mothers were recruited. In total, 78.4% of children received hepatitis B vaccination birth-dose (HepB-BD); of these, 58.7% were administered ≤ 24 h. Birth at home or "other" location were independent risk factors for children's failure to receive timely HepB-BD. Overall HBsAg seroprevalence was 4.39% (95%CI: 3.53%–5.45%) among mothers and 0.56% (95%CI: 0.32%–0.98%) among children. The prevalence among children without hepatitis B vaccination was 4.62% (95%CI: 1.31%–14.97%). Among children with a HBsAg-positive mother, prevalence was 10.11% (95%CI: 5.41%–18.11%). Interpretation: Having achieved the 2017 target of less than 1% HBsAg prevalence among 5 years old children, Cambodia can now focus on eliminating mother-to-child transmission of HBV. Moreover, the high HBsAg prevalence among mothers suggests that routine screening with proper linkage to care and treatment is needed. Strengthening measures to improve vaccination coverage further and eliminate mother-to-child transmission by coordinated programming with other services offering additional HBV interventions will help move towards the global goal of hepatitis B elimination by 2030. Funding: As per sources of funding.